Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary

Journal of Ovarian Research (Impact Factor: 2.03). 11/2012; 5(1):37. DOI: 10.1186/1757-2215-5-37
Source: PubMed

ABSTRACT Epithelial ovarian cancer (EOC) remains the most lethal of all the gynaecological malignancies with drug resistance and recurrence remaining the major therapeutic barrier in the management of the disease. Although several studies have been undertaken to understand the mechanisms responsible for chemoresistance and subsequent recurrence in EOC, the exact mechanisms associated with chemoresistance/recurrence continue to remain elusive. Recent studies have shown that the parallel characteristics commonly seen between embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSC) are also shared by a relatively rare population of cells within tumors that display stem cell-like features. These cells, termed 'cancer initiating cells' or 'cancer stem cells (CSCs)' have been shown not only to display increased self renewal and pluripotent abilities as seen in ESCs and iPSCs, but are also highly tumorigenic in in vivo mouse models. Additionally, these CSCs have been implicated in tumor recurrence and chemoresistance, and when isolated have consistently shown to express the master pluripotency and embryonic stem cell regulating gene Oct4. This article reviews the involvement of Oct4 in cancer progression and chemoresistance, with emphasis on ovarian cancer. Overall, we highlight why ovarian cancer patients, who initially respond to conventional chemotherapy subsequently relapse with recurrent chemoresistant disease that is essentially incurable.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The urge to have one's own biological child supersedes any desire in life. Several options have been used to obtain gametes including pluripotent stem cells (embryonic ES and induced pluripotent iPS stem cells); gonadal stem cells (spermatogonial SSCs, ovarian OSCs stem cells), bone marrow, mesenchymal cells and fetal skin. However, the field poses a huge challenge including inefficient existing protocols for differentiation, epigenetic and genetic changes associated with extensive in vitro manipulation and also ethical/regulatory constraints. A tremendous leap in the field occurred using mouse ES and iPS cells wherein they were first differentiated into epiblast-like cells and then primordial germ cell-like cells. These on further development produced sperm, oocytes and live offspring (had associated genetic problems). Evidently differentiating pluripotent stem cells into primordial germ cells (PGCs) remains a major bottleneck. Against this backdrop, we propose that a novel population of pluripotent stem cells termed very small embryonic-like stem cells (VSELs) may serve as an alternative, potential source of autologus gametes, keeping in mind that they are indeed PGCs surviving in adult mammalian ovaries and testes. Both VSELs and PGCs are pluripotent, relatively quiescent because of epigenetic modifications of parentally imprinted genes loci like Igf2-H19 and KCNQ1p57, share several markers like Stella, Fragilis, Mvh, Dppa2, Dppa4, Sall4, Blimp1 and functional receptors. VSELs are localized in the basement membrane of seminiferous tubules in testis and in the ovary surface epithelium. Ovarian stem cells from mouse, rabbit, sheep, marmoset and humans (menopausal women and those with premature ovarian failure) spontaneously differentiate into oocyte-like structures in vitro with no additional requirement of growth factors. Thus a more pragmatic option to obtain autologus gametes may be the pluripotent VSELs and if we could manipulate them in vivo - existing ethical and epigenetic/genetic concerns associated with in vitro culture may also be minimized. The field of oncofertility may undergo a sea-change and existing strategies of cryopreservation of gametes and gonadal tissue for fertility preservation in cancer patients will necessitate a revision. However, first the scientific community needs to arrive at a consensus about VSELs in the gonads and then work towards exploiting their potential.
    Reproductive Biology and Endocrinology 11/2014; 12(1):114. DOI:10.1186/1477-7827-12-114 · 2.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Despite extensive research genetic basis of premature ovarian failure (POF) and ovarian cancer still remains elusive. It is indeed paradoxical that scientists searched for mutations in follicle stimulating hormone receptor (FSHR) expressed on granulosa cells whereas more than 90% of cancers arise in ovary surface epithelium (OSE). Two distinct populations of stem cells including very small embryonic-like stem cells (VSELs) and ovarian stem cells (OSCs) exist in OSE, are responsible for neo-oogenesis and primordial follicle (PF) assembly in adult life and their function is modulated by FSH via its alternatively spliced receptor variant FSHR3 (growth factor type 1 receptor acting via calcium signaling and ERK/MAPK pathway). Any defect in FSH-FSHR3-stem cells interaction in OSE may affect folliculogenesis and thus result in POF. Ovarian aging is associated with a compromised microenvironment that does not support stem cells differentiation into oocytes and further folliculogenesis. FSH exerts mitogenic effect on OSE and elevated FSH levels associated with advanced age may provide a continuous trigger for stem cells to proliferate resulting in cancer, thus supporting gonadotropin theory for ovarian cancer. Present review is an attempt to put adult ovarian biology, POF, aging and cancer in the perspective of FSH-FSHR3-stem cells network that functions in OSE. This hypothesis is further supported by the recent understanding that (i) cancer is a stem cell disease and OSE is the niche for ovarian cancer stem cells (ii) ovarian stem cells are regulated by FSH and (iii) OCT4 along with LIN28 and BMP4 are highly expressed in ovarian cancers.
    Reproduction (Cambridge, England) 09/2014; DOI:10.1530/REP-14-0220 · 3.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tumor microenvironment plays an important role in cancer progression owing to interactions between the tumor and adjoining cells and, as in bone marrow, the unique ar-chitecture and chemical compounds that characterize it. It has recently been proposed that bone marrow shelters cancer cells in niches which may favor regulation of their quiescence, although the mechanisms involved have yet to be elucidated. We conjectured that a bone mar-row mimicking, calcium providing 3D biolattice recently developed by our group could affect fibrosarcoma cells in various ways, whether via its specific architecture or due to its provi-sion of calcium, an element correlated with many tumorgenic processes. In order to verify our conjecture, we examined the modifications induced in fibrosarcoma cells by this biolattice. We found that its regulatory effects on fibrosarcomas enhanced tumorigenicity, mediated by up-regulated tumorigenesis related genes. We observed decreased proliferation of cancer cells accompanied by up-regulation of genes associated with cancer stem cells, pointing to a process of de-differentiation. In addition, our results revealed up-regulation of Wnt4 and c-Myc in cells cultured on the biolattice, along with down-regulation of AXIN-1 and WIF-1. Taken together these findings suggest that a calcium rich bone marrow-like microenvironment can affect the tumorigenic capacity and fibrosarcoma cells de-differentiation through the mediation of the Wnt signaling pathway.
    11/2014; 1(1):15-25. DOI:10.17140/CSMMOJ-1-103

Full-text (4 Sources)

Available from
Feb 18, 2015